Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Emergency Use
On December 11, 2020, the
Mitchell
Article
Five Automotive Trends to Watch in 2021
None of us could have predicted the events of 2020 and their impact on the automotive industry.
Workers' Comp
News Release
AvKARE Issues Voluntary Nationwide Recall of Certain Sildenafil and Trazodone Tablets
AvKARE, Inc., a subsidiary of Amneal Pharmaceuticals located in Pulaski, Tennessee,
Auto Physical Damage
News Release
Five Automotive Trends to Watch in 2021
Workers' Comp
Article
Phoenix Rising Bonus Cuts: Survival and Recovery
As we wrap up our Inside Workers’ Comp series for the year, we thought we’d leave you with a positive podcast — a bonus extra from our inspirationa
Auto Casualty
Article
2021 Workers’ Comp Predictions: COVID-19 Effects, Automation and More
In 2020, the workers’ compensation industry has faced no shortage of challenges—treatment gaps, delays in elective surgeries, the shift to work-fro